Vimeo is coming off a big year of changes in 2017. From abandoning SVOD, to launching Vimeo Live, 360-degree video, and its first camera. The company's CEO Anjali Sud explains how these changes are driving growth for the company. New York Governor Andrew Cuomo recently proposed government funding for a study to explore the impact of legalizing recreational marijuana in the state. State Senator Gustavo Rivera (D-NY) and High NY Founder and CEO Michael Zaystev discuss the state of regulation in New York. This weekend the New York Times released an investigative piece on the dark world of buying followers and bots for social media fame and recognition. Since the report has been released, the fallout has been significant. Nicholas Confessore, reporter at the New York Times, joins Cheddar to talk about his report and what the reaction has been.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More